Abstract:
PURPOSE: Provided are a fluorescent vector, which is used for the production of vaccine of porcine Aujesky's disease and a method for selecting recombination virus using the same. CONSTITUTION: A fluorescent vector pHAVE3 is prepared by amplifying pVIII gene corresponding to 5' region of E3 gene of human Adenovirus type II, a partial sequence(27100-28811bp) having 1,712base, before open reading frame of E3 gene being 19kd, a partial sequence(30,851-32,760bp) having 1,910base, after E3-2 polyadenylation signal corresponding to 3' region of E3 gene; cloning them into SpeI of plasmid pGEMT; and inserting BamH I restriction site
Abstract:
본 발명은 송아지설사에 주로 문제시 되고 있는 소설사병 바이러스 원인체인 노로바이러스, 로타바이러스 및 코로나바이러스의 유전자 진단을 위한 프로브, 유전자칩, 유전자 증폭용 프라이머 및 이를 이용한 병원체 진단방법에 관한 것이다. 본 발명에 따르면 여러 단계를 거쳐야 하는 종래의 검사 방법과 달리 한번의 검사로 신속하게 신생우 설사병을 유발하는 주요 바이러스 원인체 및 유전형을 검사 할 수 있다.
Abstract:
The present invention relates to a manufacturing method of a vaccine against canine influenza virus capable of preventing and/or treating canine influenza virus and, more specifically, to a manufacturing method of a VLP (virus-like particle) vaccine against canine influenza virus, to the VLP vaccine against canine influenza virus manufactured by the method, and to a method for preventing canine influenza virus by inoculating dogs with the VLP vaccine against canine influenza virus manufactured by the manufacturing method. The manufacturing method of the VLP vaccine against canine influenza virus comprises: a step for amplifying hemagglutinin (HA) genes of the canine influenza virus with a sequence number 1 by a forward primer with a sequence number 2 and a reverse primer with a sequence number 3, and for PCR-amplifying matrix 1 (M1) genes of the canine influenza virus with a sequence number 4 by a forward primer with a sequence number 5 and a reverse primer with a sequence number 6; a step for cloning the amplified HA genes and M1 genes to a vector; and a step for VLP-manifesting the vector cloned with the amplified HA genes and M1 genes in insect cells.